Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors

被引:0
|
作者
Gerhard König
Peter Chiba
Gerhard F. Ecker
机构
[1] University of Vienna,Emerging Field Pharmacoinformatics, Department of Medicinal Chemistry
[2] Medical University of Vienna,Institute of Medical Chemistry
关键词
Computer chemistry; Propafenone; Multidrug resistance; Molecular modeling; Antitumor agents.;
D O I
暂无
中图分类号
学科分类号
摘要
Lipophilicity is one of the major determining physicochemical descriptors for P-glycoprotein (P-gp) inhibitory activity. In order to consider lipophilicity as a space directed property, we apply the concept of hydrophobic moments on a set of propafenone-type inhibitors of P-glycoprotein and use them as descriptors in QSAR analyses. While the 0th moment is the sum of the atomic hydrophobicity coefficients, which is a measure for the total hydrophobicity of the molecule, the 1st moment (or hydrophobic dipole) is a measure for the asymmetry of the distribution of hydrophobicities and therefore is analogous to the electrostatic dipole. The use of these hydrophobic dipole moments as independent variables remarkably improved the predictive power of QSAR models obtained.
引用
收藏
页码:401 / 405
页数:4
相关论文
共 50 条
  • [1] Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors
    Koenig, Gerhard
    Chiba, Peter
    Ecker, Gerhard F.
    MONATSHEFTE FUR CHEMIE, 2008, 139 (04): : 401 - 405
  • [2] Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors
    Wang, RB
    Kuo, CL
    Lien, LL
    Lien, EJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (03) : 203 - 228
  • [3] Recent developments of P-glycoprotein inhibitors and its structure-activity relationship (SAR) studies
    Zhao, Xuanming
    Di, Jing
    Luo, Dingjie
    Vaishnav, Yogesh
    Kamal
    Nuralieva, Nargiza
    Verma, Deepti
    Verma, Payal
    Verma, Shekhar
    BIOORGANIC CHEMISTRY, 2024, 143
  • [4] Structure-activity relationship of P-glycoprotein substrates and modifiers
    Seelig, A
    Landwojtowicz, E
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) : 31 - 40
  • [5] Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements
    Schmid, D
    Ecker, G
    Kopp, S
    Hitzler, M
    Chiba, P
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (09) : 1447 - 1456
  • [6] Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors
    Chen, Chien-Yu
    Lin, Chin-Min
    Lin, Hui-Chang
    Huang, Chien-Fu
    Lee, Chih-Yu
    Tou, Tze-Chun Si
    Hung, Chin-Chuan
    Chang, Chih-Shiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 1023 - 1035
  • [7] Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model
    Gombar, VK
    Polli, JW
    Humphreys, JE
    Wring, SA
    Serabjit-Singh, CS
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (04) : 957 - 968
  • [8] Cytocompatibility and P-glycoprotein Inhibition of Block Copolymers: Structure-Activity Relationship
    Cambon, A.
    Brea, J.
    Loza, M. I.
    Alvarez-Lorenzo, C.
    Concheiro, A.
    Barbosa, S.
    Taboada, P.
    Mosquera, V.
    MOLECULAR PHARMACEUTICS, 2013, 10 (08) : 3232 - 3241
  • [9] Extending the structure-activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors
    Yang, Chao
    Wong, Iris L. K.
    Peng, Kai
    Liu, Zhen
    Wang, Peng
    Jiang, Tingfu
    Jiang, Tao
    Chow, Larry M. C.
    Wan, Sheng Biao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 795 - 806
  • [10] Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein
    Ekins, S
    Kim, RB
    Leake, BF
    Dantzig, AH
    Schuetz, EG
    Lan, LB
    Yasuda, K
    Shepard, RL
    Winter, MA
    Schuetz, JD
    Wikel, JH
    Wrighton, SA
    MOLECULAR PHARMACOLOGY, 2002, 61 (05) : 964 - 973